In the European medical devices industry, there were 9 private equity deals announced in Q3 2023, worth a total value of $6.9bn, according to GlobalData’s Deals Database. The $3bn Institutional Buy-out (IBO) Synlab by Ephios Luxembourg was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in Europe increased by 1916% in Q3 2023 compared with the previous quarter’s total of $342.2m and rose by 3566% as compared to Q3 2022. Related deal volume remained flat in Q3 2023 versus the previous quarter and was 31% lower than in Q3 2022.
The top-ranked financial advisors supporting these private equity deals in Europe in Q3 2023 were Rothschild & Co; Bank of America; Barclays with 2, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Europe Q3 2023 were Kirkland & Ellis; Allen & Overy; Paul Hastings with 3, 2, 2 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2023 – Thematic Intelligence, buy the report here.